Summit Therapeutics PLC (SMMT) — Cash Flow Quality Index
Summit Therapeutics PLC (SMMT) has a Cash Flow Quality Index of -0.38x as of June 2018. Operating cash flow of $-13.86 Million is below net income of $36.06 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore SMMT cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Summit Therapeutics PLC Cash Flow Quality Index (2018–2018)
Historical Cash Flow Quality Index for Summit Therapeutics PLC across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does Summit Therapeutics PLC generate cash.
Annual Cash Flow Quality Index for Summit Therapeutics PLC (2018–2018)
Year-by-year earnings quality comparison for Summit Therapeutics PLC.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2018 | -3.23x | $-35.11 Million | $10.87 Million | — |